I was nearly going to get excited, till read the comments on Heart and Renal. I understand the Oncology market as the bread and butter, but to delay Heart and Renal will allow another player to progress into this ahead of IPD, even if there technology is not as advanced.
- Forums
- ASX - By Stock
- IPD
- Ann: Market Update - Executing Towards Profitability in Oncology
IPD
impedimed limited
Add to My Watchlist
0.00%
!
3.6¢

Ann: Market Update - Executing Towards Profitability in Oncology, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $72.98M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 417460 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.8¢ | 552269 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 427120 | 0.036 |
2 | 390000 | 0.035 |
3 | 338208 | 0.034 |
1 | 638321 | 0.033 |
3 | 459150 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.038 | 566404 | 3 |
0.039 | 865746 | 2 |
0.040 | 777500 | 4 |
0.041 | 250000 | 1 |
0.042 | 138405 | 2 |
Last trade - 12.03pm 07/07/2025 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online